Table 2 Sample selection

Total number of patients with ≥1 inpatient admissions for treatment of condition of interest* during study period** and

Received oral ziprasidone, ariprazole, or quetiapine on the day of discharge or immediately preceding one and

≥6 months enrollment prior to “qualifying” admission and

≥6 months enrollment subsequent to date of discharge of “qualifying” admission and

Had no evidence of receipt of clozapine at any time during study period and

Were not enrolled in insurance plan with mental health “carve out” and

Were aged ≥18 years as of date of qualifying hospital admission and

Had no evidence of epilepsy prior to qualifying admission and

Had no evidence of other condition of interest* during study period